Expression of Bone Morphogenetic Protein-7 (BMP-7) in Human Prostate

Prostate

Volumn 59, Issue 1, 2004, Pages 101-106

  Masuda, Hiroshi ^a   Fukabori, Yoshitatsu ^a   Nakano, Katsuya ^a   Shimizu, Nobuaki ^a   Yamanaka, Hidetoshi ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Androgen ablation; Bone morphogenetic protein 7; Human prostate; Polymerase chain reaction; Prostate cancer

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; OSTEOGENIC PROTEIN 1;

ARTICLE; BONE TISSUE; GENE EXPRESSION REGULATION; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECURRENT CANCER; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; RNA EXTRACTION;

AGED; BONE MORPHOGENETIC PROTEINS; CELL LINE, TUMOR; DIHYDROTESTOSTERONE; DISEASE PROGRESSION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 1642402864     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20030     Document Type: Article

References (35)

1. The Japanese Ministry of Health and Welfare Research Committee. The Japanese Annual Report of the Ministry of Health and Welfare Research Committee. The Japanese Ministry of Health and Welfare, Tokyo, 1952-2000.
2. Charhon SA, Chapuy MC, Delvin EE, Valentin-opran A, Edouard CM, Meunier PJ. Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalacia. Cancer 1983;51:918-924.
3. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-573.
4. Hart IR, Saini A. Biology of tumour metastasis (see comments). Lancet 1992;339:1453-1457.
5. Orr FW, Sanchez-Sweatman OH, Kostenuik P, Singh G. Tumor-bone interactions in skeletal metastasis. Clin Orthop 1995;312:19-33.
6. Koutsilieris M. Osteoblastic metastasis in advanced prostate cancer. Anticancer Res 1993;13:443-449.
7. Mydlo JH, Michaeli J, Heston WDW, Fair WR. Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinoma. Prostate 1988;12:343-355.
8. Mori H, Maki M, Oishi K, Jaye M, Igarashi K, Yoshida O, Hatanaka M. Increased expression of genes for basic fibroblast growth factor and transforming growth factor type β-2 in human benign prostatic hyperplasia. Prostate 1990;16:71-80.
9. Thompson TC. Growth factors and oncogenes in prostate cancer. Cancer Cells 1990;2:345-354.
10. Urist MR. Bone formation by autoinduction. Science (Washington DC) 1965;150:893-899.
11. Dube JL, Celeste AJ. Human bone morphogenetic protein-15, new member of the transforming growth factor β superfamily. J Bone Miner Res 1996;11(Suppl 1):T330.
12. Vukicevic S, Luyten FP, Reddi AH. Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin. Proc Natl Acad Sci 1989;86:8793-8797.
13. Reddi AH. Bone and cartilage differentiation. Curr Opin Genet Dev 1994;4:737-744.
14. Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Katagiri T, Wozney JM, Rosen V, Yoshiki S. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 1996;220:366-371.
15. Bently H, Hamdy FC, Hart KA, Seid JM, Williams JL, Johnstone D, Russel RG. Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer 1992;66:1159-1163.
16. Harris SE, Harris MA, Mahy P, Wozney J, Feng JQ, Mundy GR. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate 24:204-211.
17. Barns J, Anthony CT, Wall N, Steiner MS. Bone morphogenetic protein-6 expression in normal and malignant prostate. World J Urol 1995;13:337-343.
18. Chen D, Feng JQ, Feng M, Harris MA, Mahy P, Mundy GR, Harris SE. Sequence and expression of bone morphogenetic protein-3 messenger-RNA in prolonged cultures of fetal-rat calvarial osteoblasts and in rat prostate adenocarcinoma PA-III cell. DNA Cell Biol 1995;14:235-239.
19. Hamdy FC, Autzen P, Robinson MC, Wilson Horne CH, Neal DE, Robinson CN. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue. Cancer Res 1997;57:4427-4431.
20. Thomas R, Anderson AA, Raman V, Reddi AH. Androgen-dependent gene expression of bone morphogenetic protein 7 in mouse prostate. Prostate 1998;37:236-245.
21. Masuda H, Fukabori Y, Nakano K, Takezawa Y, Suzuki T, Yamanaka H. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer. Prostate 2003;54:268-274.
22. Heid CA, Stevens J, Livak KJ, Willams PM. Real time quantitative PCR. Genome Res 1996;6:986-994.
23. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res 1996;6:995-1001.
24. Williams-Ashman HG, Reddi AH. Androgenic regulation of tissue growth and function. In: Litwack G, editor. Biochemical action of hormones, Vol. 2, New York: Academic Press; 1972. 357-394.
25. Noble RL. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 1977;37:1929-1933.
26. Huggins CB, Hodges CV. Studies on prostate cancer: Effect of castration, of estrogen, and of androgen injection on serum phosphatase in metastatic carcinoma of the prostate. Cancer Res 1941;1:293-297.
27. Buttyan R, Zakeri Z, Lockshin R, Wolgemuth D. Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of rat ventral prostate gland. Mol Endocrinol 1988;2:650-657.
28. Cunningham NS, Paralkar V, Reddi AH. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci USA 1992;89:11740-11744.
29. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whiters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242:1528-1534.
30. Partin AW, Coffey DS. The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell's urology, (7th edn.) Philadelphia: WB Saunders; 1998. pp 1381-1428.
31. Huggins CB. The formation of bone under the influence of epithelium of the urinary tract. Arch Surg 1931;22:377-408.
32. Hogan BL. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 1996;10:1580-1594.
33. Lind M, Eriksen EF, Bunger C. Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. Bone 1996;18:53-57.
34. Paraklar VM, Weeks BS, Yu YM, Kleinman HK, Reddi AH. Recombinant human bone mophogenetic protein 2B stimulates12 cell differentiation: Potentiation and binding to type IV collagen. J Cell Biol 1992;119:1721-1728.
35. Ozkaynak E, Schnegelsberg PN, Oppermann H. Murine osteogenic protein (OP-1): High levels of mRNA in kidney. Biochem Biophys Res Commun 1991;179:116-123.